NCT01919164 arm group 4331996787684477e1c9b02cf0580be6 [clinicaltrials_resource:NCT01919164/arm-group/4331996787684477e1c9b02cf0580be6]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01919164 arm group 4331996787684477e1c9b02cf0580be6 [clinicaltrials_resource:NCT01919164/arm-group/4331996787684477e1c9b02cf0580be6]
Bio2RDF identifier
NCT01919164/arm-group/4331996787684477e1c9b02cf0580be6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 31996787684477e1c9b02cf0580be6
description [clinicaltrials_vocabulary:description]
AS902330 will be administered ...... ks, with follow-up to 2 years.
identifier
clinicaltrials_resource:NCT01919164/arm-group/4331996787684477e1c9b02cf0580be6
title
NCT01919164 arm group 4331996787684477e1c9b02cf0580be6
@en
type
label
NCT01919164 arm group 43319967 ...... 1996787684477e1c9b02cf0580be6]
@en